Need Help? Call 1­-866-­796-­7386
« back to stock screener

  REPH stock: Recro Pharma Inc

Current Rating
Strong Buy

Previous Rating

Strong Buy
Our Strong Buys
double the S&P500!
Learn more.
Company Statistics
Price
$2.10
Market Cap
114M
Sector
Health Care
Div. Growth
-
P/E
-
P/B
3.56
P/S
1.47
Dividend %
-
P/CF
4.8
P/FCF
-
Op. Cash Flow
6.4K
FCF
0.0
Op. Margin
-3.80%
Net Margin
-30.20%
ROE
669.80%
ROI
-8.70%
ROA
-18.20%
EPS Growth
52.40%
Current Ratio
6.9
Debt/Equity
-
Company Price P/E Div. Yield Market Cap ($Mil) Rating
Inogen Inc (INGN) $46.75 - - 1.36B Strong Buy
Tempest Therapeutics Inc (TPST) $15.15 - - 99.7M Strong Buy
China Pharma Holdings, Inc. (CPHI) $0.59 - - 30.3M Strong Buy
Cidara Therapeutics Inc (CDTX) $2.14 - - 107.4M Strong Buy
Rigel Pharmaceuticals, Inc. (RIGL) $3.71 - - 709M Strong Buy
Find great stocks now!
Avoid risky stocks
Enter your favorite tickers and click “Get Ratings”

Disclaimer

Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.

All analysis relies on publicly available financial information. Learn More